|
T&R Derma, the new Dermatology Division of Thornton and Ross, has recently launched Aquamol® – a new emollient cream with a unique formulation to penetrate and rehydrate the skin. Clinical trials have shown excellent results with a 30% overall improvement in skin condition, itching and sleep disturbance. Aquamol is now available on prescription.
Aquamol is a uniquely formulated emulsion of oil in water, containing penetration enhancers that carry the water through the lipid barrier to the upper layers of the skin. Aquamol also occludes the skin to maximise and maintain hydration. When first applied, Aquamol appears white but turns clear after a few seconds of smoothing into the skin. At this point the skin is occluded, locking in the hydration.
Aquamol was evaluated in two clinical trials with more than 100 children aged between 1 and 12 years. After 12 weeks’ treatment with Aquamol, there was a 30% reduction in the mean SCORAD scores (SCORing Atopic Dermatitis), which includes a patient/parent self-assessment of symptom severity.
The trials also showed a reduction in skin dryness of 34%. And skin itching was reduced by 30%, showing Aquamol to be effective where itching is a problem.
As with all emollients, what suits one person won’t suit another but the wider the available range of options the more likely we are to find one that works well for us.
Aquamol is available on prescription in 50-g tubes and 500-g airless pump dispensers.
Aquamol is suitable for adults and children over one year old. To keep the skin well hydrated, it should be applied frequently and at regular intervals.
|